Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease

被引：57

作者：

Bianchi, Elena ^{[1
]}

Pascual, Manuel ^{[2
]}

Nicod, Marie ^{[3
]}

Delaloye, Angelika Bischof ^{[3
]}

Duchosal, Michel A. ^{[1
]}

机构：

[1] Univ Hosp Lausanne CHUV, Serv Hematol, CH-1011 Lausanne, Switzerland

[2] Univ Hosp Lausanne CHUV, Transplantat Ctr, CH-1011 Lausanne, Switzerland

[3] Univ Hosp Lausanne CHUV, Nucl Med Serv, CH-1011 Lausanne, Switzerland

来源：

TRANSPLANTATION | 2008年 / 85卷 / 05期

关键词：

posttransplant lymphoproliferative disease; positron emission tomography; computed tomography;

D O I：

10.1097/TP.0b013e3181661676

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

Background. Posttransplant lymphoproliferative disease (PTLD) is, aside skin cancer, the most common malignancy occurring after solid organ transplant in adults. Fluorodeoxyglucose (FDG) positron emission tomography (PET) has proved useful in the management of lymphomas. Methods. We report our experience with the use of FDG-PET inline with computed tomography (CT) scanning in the management of four transplant recipients with histologically confirmed PTLD, including three monomorphic PTLDs and one polymorphic PTLD. Results. FDG-PET/CT scan at diagnosis showed increased FDG uptake in all examined PTLD lesions, and the disease was upstaged on the basis of FDG-PET/CT scan results over conventional CT scanning in one patient. At the end of treatment, PET/CT scans no longer demonstrated FDG uptake in the original PTLD lesions in all patients. Complete remission of disease persisted for at least 1 year after diagnosis in all. Conclusions. Our results strongly support that FDG-PET scanning is highly specific for diagnosis and follow-up of PTLD. The clinical relevance of including FDG-PET/CT scanning in the management of PTLD should be evaluated in a larger prospective cohort study.

引用

页码：707 / 712

页数：6

共 15 条

[1]

PTLD visualization by FDG-PET: Improved detection of extranodal localizations [J].

Bakker, N. A. ;

Pruim, J. ;

de Graaf, W. ;

van Son, W. J. ;

van der Jagt, E. J. ;

van Imhoff, G. W. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (08) :1984-1985

[2]

Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation [J].

Bakker, Nicolaas A. ;

van Imhoff, Gustaaf W. ;

Verschuuren, Erik A. M. ;

van Son, Willem J. .

TRANSPLANT INTERNATIONAL, 2007, 20 (03) :207-218

[3]

Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[4]

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial [J].

Haddad, E ;

Paczesny, S ;

Leblond, V ;

Seigneurin, JM ;

Stern, M ;

Achkar, A ;

Bauwens, M ;

Delwail, V ;

Debray, D ;

Duvoux, C ;

Hubert, P ;

de Ligny, BH ;

Wijdenes, J ;

Durandy, A ;

Fischer, A .

BLOOD, 2001, 97 (06) :1590-1597

[5]

Harris N. L., 2000, Histopathology (Oxford), V36, P69

[6]

Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma [J].

Hernandez-Maraver, Dolores ;

Hernandez-Navarro, Fernando ;

Gomez-Leon, Nieves ;

Coya, Juan ;

Rodriguez-Vigil, Beatriz ;

Madero, Rosario ;

Pinilla, Immaculada ;

Martin-Curto, Luis M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) :293-302

[7]

Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma [J].

Juweid, Malik E. ;

Stroobants, Sigrid ;

Hoekstra, Otto S. ;

Mottaghy, Felix M. ;

Dietlein, Markus ;

Guermazi, Ali ;

Wiseman, Gregory A. ;

Kostakoglu, Lale ;

Scheidhauer, Klemens ;

Buck, Andreas ;

Naumann, Ralph ;

Spaepen, Karoline ;

Hicks, Rodney J. ;

Weber, Wolfgang A. ;

Reske, Sven N. ;

Schwaiger, Markus ;

Schwartz, Lawrence H. ;

Zijlstra, Josee M. ;

Siegel, Barry A. ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :571-578

[8]

Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission [J].

Knoop, C ;

Kentos, A ;

Remmelink, M ;

Garbar, C ;

Goldman, S ;

Feremans, W ;

Estenne, M .

CLINICAL TRANSPLANTATION, 2006, 20 (02) :179-187

[9]

Post-transplant.lymphoproliferative disorders [J].

LaCasce, Ann S. .

ONCOLOGIST, 2006, 11 (06) :674-680

[10]

Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients [J].

Marom, EM ;

McAdams, HP ;

Butnor, KJ ;

Coleman, RE .

JOURNAL OF THORACIC IMAGING, 2004, 19 (02) :74-78

← 1 2 →